| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of rotavirus genotypes in Korea during 2013: An increase in the G2P[4] genotype after the introduction of rotavirus vaccines
|
Kim, Jae-Seok
|
|
2014
|
32 |
48 |
p. 6396-6402
7 p.
|
artikel
|
| 2 |
An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization
|
Raghunandan, Rama
|
|
2014
|
32 |
48 |
p. 6485-6492
8 p.
|
artikel
|
| 3 |
A response to Fu et al.’s “Educational interventions to increase HPV vaccination acceptance”
|
Shapiro, Gilla K.
|
|
2014
|
32 |
48 |
p. 6342-6344
3 p.
|
artikel
|
| 4 |
A seroprevalence survey on varicella among adults in the vaccination era in Apulia (Italy)
|
Tafuri, S.
|
|
2014
|
32 |
48 |
p. 6544-6547
4 p.
|
artikel
|
| 5 |
Better vaccines for healthier life. Part I. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam
|
Pagliusi, Sonia
|
|
2014
|
32 |
48 |
p. 6325-6329
5 p.
|
artikel
|
| 6 |
Better vaccines for healthier life. Part II. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam
|
Pagliusi, Sonia
|
|
2014
|
32 |
48 |
p. 6330-6335
6 p.
|
artikel
|
| 7 |
Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines?
|
Donahue, James G.
|
|
2014
|
32 |
48 |
p. 6440-6444
5 p.
|
artikel
|
| 8 |
Changes in the incidence of Streptococcus pneumoniae bacteremia and its serotypes over 10 years in one hospital in South Korea
|
Park, Miey
|
|
2014
|
32 |
48 |
p. 6403-6407
5 p.
|
artikel
|
| 9 |
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
|
Scheiermann, Julia
|
|
2014
|
32 |
48 |
p. 6377-6389
13 p.
|
artikel
|
| 10 |
Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece
|
Grivea, Ioanna N.
|
|
2014
|
32 |
48 |
p. 6513-6520
8 p.
|
artikel
|
| 11 |
Editorial Board/Aims and Scope
|
|
|
2014
|
32 |
48 |
p. IFC-
1 p.
|
artikel
|
| 12 |
Efficacy of Type 2 PRRSV vaccine against Chinese and Vietnamese HP-PRRSV challenge in pigs
|
Lager, Kelly M.
|
|
2014
|
32 |
48 |
p. 6457-6462
6 p.
|
artikel
|
| 13 |
Elevated serum anti-phosphatidylcholine IgG antibodies in patients with influenza vaccination-associated optic neuritis
|
Korematsu, Seigo
|
|
2014
|
32 |
48 |
p. 6345-6348
4 p.
|
artikel
|
| 14 |
Evaluation of avian influenza virus isolated from ducks as a potential live vaccine candidate against novel H7N9 viruses
|
Jiang, Wen-Ming
|
|
2014
|
32 |
48 |
p. 6433-6439
7 p.
|
artikel
|
| 15 |
Hepatitis B: Are at-risk individuals vaccinated if screened and found negative for HBV? Results of an online survey conducted in six EU countries
|
Levi, Miriam
|
|
2014
|
32 |
48 |
p. 6415-6420
6 p.
|
artikel
|
| 16 |
H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine
|
Khurana, Surender
|
|
2014
|
32 |
48 |
p. 6421-6432
12 p.
|
artikel
|
| 17 |
HPV vaccine coverage among men who have sex with men – National HIV Behavioral Surveillance System, United States, 2011
|
Meites, Elissa
|
|
2014
|
32 |
48 |
p. 6356-6359
4 p.
|
artikel
|
| 18 |
Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study
|
Gordon, David
|
|
2014
|
32 |
48 |
p. 6469-6477
9 p.
|
artikel
|
| 19 |
Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: A randomized, double-blind, lot-to-lot consistency trial
|
Umeh, Rich
|
|
2014
|
32 |
48 |
p. 6556-6562
7 p.
|
artikel
|
| 20 |
Influence of antibodies transferred by colostrum in the immune responses of calves to current foot-and-mouth disease vaccines
|
Bucafusco, Danilo
|
|
2014
|
32 |
48 |
p. 6576-6582
7 p.
|
artikel
|
| 21 |
Influenza vaccine as prevention for cardiovascular diseases: Possible molecular mechanism
|
Veljkovic, Veljko
|
|
2014
|
32 |
48 |
p. 6569-6575
7 p.
|
artikel
|
| 22 |
Inpatient admission for febrile seizure and subsequent outcomes do not differ in children with vaccine-associated versus non-vaccine associated febrile seizures
|
Tartof, Sara Y.
|
|
2014
|
32 |
48 |
p. 6408-6414
7 p.
|
artikel
|
| 23 |
Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice
|
Fuchs, Jeremy
|
|
2014
|
32 |
48 |
p. 6537-6543
7 p.
|
artikel
|
| 24 |
Low pertussis toxin antibody levels in two regional cohorts of Canadian pregnant women
|
Bigham, Mark
|
|
2014
|
32 |
48 |
p. 6493-6498
6 p.
|
artikel
|
| 25 |
Multimodality vaccination against clade C SHIV: Partial protection against mucosal challenges with a heterologous tier 2 virus
|
Lakhashe, Samir K.
|
|
2014
|
32 |
48 |
p. 6527-6536
10 p.
|
artikel
|
| 26 |
PCV7-induced changes in pneumococcal carriage and invasive disease burden in Alaskan children
|
Keck, James W.
|
|
2014
|
32 |
48 |
p. 6478-6484
7 p.
|
artikel
|
| 27 |
Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing
|
Donis, Ruben O.
|
|
2014
|
32 |
48 |
p. 6583-6590
8 p.
|
artikel
|
| 28 |
Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005–June 2013
|
Haber, Penina
|
|
2014
|
32 |
48 |
p. 6499-6504
6 p.
|
artikel
|
| 29 |
Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins
|
Bissett, Sara L.
|
|
2014
|
32 |
48 |
p. 6548-6555
8 p.
|
artikel
|
| 30 |
Prevalence and determinants of influenza vaccine coverage at tertiary pediatric hospitals
|
Newcombe, James
|
|
2014
|
32 |
48 |
p. 6364-6368
5 p.
|
artikel
|
| 31 |
Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus
|
Peeters, Ben
|
|
2014
|
32 |
48 |
p. 6445-6450
6 p.
|
artikel
|
| 32 |
Relative timing of influenza disease by age group
|
Peters, Timothy R.
|
|
2014
|
32 |
48 |
p. 6451-6456
6 p.
|
artikel
|
| 33 |
Report of the 7th African Rotavirus Symposium, Cape Town, South Africa, 8th November 2012
|
Seheri, L.M.
|
|
2014
|
32 |
48 |
p. 6336-6341
6 p.
|
artikel
|
| 34 |
Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients
|
Gilbert, Christopher L.
|
|
2014
|
32 |
48 |
p. 6521-6526
6 p.
|
artikel
|
| 35 |
Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: A population-based study in Taiwan
|
Huang, Wan-Ting
|
|
2014
|
32 |
48 |
p. 6463-6468
6 p.
|
artikel
|
| 36 |
Seasonal influenza vaccination trends from 2007–2011 in privately insured children and adults in the United States
|
Antonova, Evgeniya
|
|
2014
|
32 |
48 |
p. 6563-6568
6 p.
|
artikel
|
| 37 |
Seasonal influenza vaccine dose distribution in 157 countries (2004–2011)
|
Palache, Abraham
|
|
2014
|
32 |
48 |
p. 6369-6376
8 p.
|
artikel
|
| 38 |
Survey of pediatricians in Germany reveals important challenges for possible implementation of meningococcal B vaccination
|
Takla, Anja
|
|
2014
|
32 |
48 |
p. 6349-6355
7 p.
|
artikel
|
| 39 |
The establishment of sub-strain specific WHO Reference Reagents for BCG vaccine
|
Dagg, Belinda
|
|
2014
|
32 |
48 |
p. 6390-6395
6 p.
|
artikel
|
| 40 |
The impact of introducing new vaccines on the health system: Case studies from six low- and middle-income countries
|
Burchett, Helen E.D.
|
|
2014
|
32 |
48 |
p. 6505-6512
8 p.
|
artikel
|
| 41 |
Vaccine safety implications of Ontario, Canada's switch from DTaP–IPV to Tdap–IPV for the pre-school booster
|
Klar, Salman
|
|
2014
|
32 |
48 |
p. 6360-6363
4 p.
|
artikel
|
Tijdschrift beschrijving